FindTrial
Sign In

Observational study on clinical characteristics and prognosis of severe amlodipine poisoning

Observational study on clinical characteristics and prognosis of severe amlodipine poisoning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083687
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe amlodipine poisoning

Interventions

Amlodipine poisoning group:NA

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to No maximum

Inclusion criteria

Inclusion criteria: ? Age = 13 years; ? There is a clear history of taking CCBs in a short period of time (within 48h); ? Clinical manifestations of CCBs poisoning.

Exclusion criteria

Exclusion criteria: ? age less than 12 years old; ? The hospitalization time is less than 24 hours; ? Unable to obtain the patient's prognosis information.

Design outcomes

Primary

MeasureTime frame
Incidence of high output heart failure;Incidence of pulmonary hypertension;—

Secondary

MeasureTime frame
Dosage of vasoactive drugs;Mechanical ventilation time;Length of ICU stay;Total length of stay;28-day mortality rate;—

Countries

China

Contacts

Public ContactDingyu Tan

Northern Jiangsu People's Hospital

32494845@qq.com+86 180 5106 1672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026